1. Curriculum Vitae
Full first and surname (capital letters): Andriy Sapatyi
Professionalphone number: +380637550557,+380669838448
Email Address: asapatyimed@gmail.com
Academic Qualification(s)
(e.g. MD, MBBS, Medical License Number, etc):
 M.D., PhD, Associate professor the chair of clinical pharmacology and
pharmacotherapy
Address
(Name of Institution, Street, City, Postal Code, State or Province (if applicable),
Country):
 Ivano-Frankivsk Regional Clinical Cardiological Center, Department of
Arterial Hypertension, SHEI „Ivano-Frankivsk National Medical
University“, Chair of clinical pharmacology and pharmacotherapy, 114
H.Mazepy Str., Ivano-Frankivsk, 76018, Ukraine
Education and Training
(List all Colleges, Universities and Medical Schools attended,
postdoctoral/fellowship training, board certification/medical license):
Name and Location of Institution
(City, State or Province and
Country)
Degree and Year
Awarded Area of Study
SHEI “Ivano-Frankivsk State
Medical University”, Ivano-
Frankivsk, Ukraine
2004-2005 Internship - Internal
Medicine (Therapy)
SHEI “Ivano-Frankivsk State
Medical University”, Ivano-
2005-2008 Postgraduate study
for PhD (Clinical

2. Frankivsk, Ukraine
SE “Institute of Pharmacology and
Toxicology”,
Academy of Medical Sciences of
Ukraine, Kyiv, Ukraine
pharmacology)
SHEI “Ivano-Frankivsk National
Medical University”, Ivano-
Frankivsk, Ukraine
2004-2011 Assistant of the
chair of clinical
pharmacology and
pharmacotherapy
with courses of
bioethics and
biosafety
SHEI “Ivano-Frankivsk National
Medical University”, Ivano-
Frankivsk, Ukraine
2011 – present time Associate professor
(PhD) of the chair
of clinical
pharmacology and
pharmacotherapy
Professional Experience
Position/Title
Name and Location of
Institution
(City, State or Province and
Country)
Dates
(Start/Stop
Dates as
applicable)

3. Current
Associate professor (PhD)
of the chair of clinical
pharmacology and
pharmacotherapy
SHEI „Ivano-Frankivsk
National Medical University“,
Chair of clinical
pharmacology and
pharmacotherapy, Ivano-
Frankivsk, Ukraine
2011 – present
time
Current
Vice-dean of dean's office
of the foreign student
department
SHEI „Ivano-Frankivsk
National Medical University“,
Ivano-Frankivsk, Ukraine
2009 – present
time
Previous
Assistant of the chair of
clinical pharmacology and
pharmacotherapy with
courses of bioethics and
biosafety
SHEI „Ivano-Frankivsk
National Medical University“,
Chair of clinical
pharmacology and
pharmacotherapy with courses
of bioethics and biosafety
2004-2011
Previous participation in clinical trials
Indication of Trial
Clinical
Phase of
Trial (I-IV)
Role in Trial (e.g.
Investigator, Sub-
Investigator)
Year in
which trial
was
conducted
A phase 2,
randomized, parallel
group, multi-center,
multi-national study
for the evaluation of
safety of four fixed
II Sub-Investigator
Study Coordinator
2007-2008

4. dose regimens of
oral anticoagulant drug
which acts as a direct
factor Xa inhibitor in
subjects with non-
valvular atrial
fibrillation.
A phase 3,
Randomized, Double-
Blind, Double-
Dummy, Parallel
Group, Multi-Center,
Multi-National Study
for Evaluation of
Efficacy and Safety of
oral anticoagulant drug
which acts as a direct
factor Xa inhibitor
Versus a vitamin K
antagonist in Subjects
with Atrial Fibrillation
– Effective
Anticoagulation with
Factor Xa Next
Generation in Atrial
Fibrillation
III Sub-Investigator 2009-2013
Study assessing the
morbidity-mortality
benefits of the If
inhibitor in patients
with coronary artery
III Sub-Investigator 2011-2013

5. disease
A Multi-Center,
Prospective,
Randomized, Double-
Blind, Placebo-
Controlled, Parallel-
Group Study to
Evaluate the Effect of
omega-3-carboxylic
acids on
Cardiovascular Health
and Mortality in
Hypertriglyceridemic
Patients with
Cardiovascular
Disease or at High
Risk for
Cardiovascular
Disease
III Sub-Investigator 2012-
ongoing
Prospective,
multicentre,
international Registry
of male and female
patients newly
diagnosed with atrial
fibrillation
Prospective Sub-Investigator 2012-
ongoing
Efficacy and safety of
fixed-dose
combination ACE
III Sub-Investigator 2013-2015

6. inhibitor 5 mg /
thiazide-like diuretic
1.25 mg / Ca-channels
blocker 5 mg versus
ACE inhibitor 5 mg /
thiazide-like diuretic
1.25 mg single pill in
patients with
uncontrolled essential
hypertension after 1
month of treatment by
ACE inhibitor
5 mg / thiazide-like
diuretic 1.25 mg single
pill. An international,
multicentre,
randomised, double
blind, 12-weeks
superiority study.
Training on ICH/GCP: YES If yes, specify below NO
 Introduction to the Clinical Drug Development Process: ICH Good
Clinical Practice for Clinical Trial Sites, February 8, 2016
Published works in foreign journals:
 Sapatyi Andriy, Kupnovytska I.G., Dzvinyatska O.F., Belegai R.I.,
Kutynska I.P. Prospects of research of drugs with metabolic action in the
treatment of the patients with heart’s diseases // 6th Global CardioVascular
Clinical Trialists Forum – Paris 2009, P.53
 Andriy Sapatyi, Iryna Kupnovytska New antioxidant properties of Corvitin
in the treatment of patients with acute myocardial infarction and chronic

7. heart failure // 9th Global Cardiovascular Clinical Trialists Foum – 30 Nov
2012 – 01 Dec 2012, Paris
 A. Sapatyi, І.G. Kupnovytska, R.I. Belegai Evaluation of endothelial
dysfunction in patients with arterial hypertension and chronic heart failure //
Heart failure, May 2014, ESC, P.871
 A. Sapatyi, І.G. Kupnovytska, R.I. Belegai Evaluation of quality of life of
patients with acute myocardial infarction, developed and ran on the
background of arterial hypertension and chronic heart failure // Heart failure,
May 2014, ESC, P.872
 A. Sapatyi, R. Belegai, L. Kovalchuk Corrective action of soluble Quercetin
on cardiac arrhythmias induced by peroxynitrite in vitro // 2nd World
Congress on Acute Heart Failure as a main part of the congress. Seviile,
Spain, 23-26 May 2015. P1067
 A. Sapatyi, R. Belegai, I. Kupnovytska, L. Kovalchuk Prevention of
arrhythmias in patients with acute myocardial infarction during treatment
with bioflavonoids // 2nd World Congress on Acute Heart Failure as a main
part of the congress. Seviile, Spain, 23-26 May 2015. P277
Date: _____________________
Signature__________________ Andriy Sapatyi